Answer
Elrexfio (elranatamab) is contraindicated in anyone with hypersensitivity to elranatamab or any of its excipients listed in section 6.1 of the product information.
Sources for this answer
- ELREXFIO 40 mg/mL solution for injectionPfizer Limited · emc · SmPC §4.3 Contraindications · Version 8Document updated
Sources checked